Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGermans Trias i Pujol Hospital

About this trial

Endoscopic retrograde cholangiopancreatography (ERCP) is a technique which combines endoscopic and radiological vision and allows for therapeutic procedures on pathologies of the pancreas and bile duct.

ERCP is a generally well tolerated procedure, nonetheless it is a complex technique that has a higher frequency of complications compared to most endoscopic procedures that can even be life-threatening. These complications are related to patient characteristics, experience of the endoscopist performing the procedure, and specific factors to the technique. Due to its complexity, quality assurance, operator training and auditing are required to increase success and minimize complications.

There are quality indicators suggested by the main scientific societies in relation to technical aspects and complications, recommending their monitoring and auditing. Most endoscopy units lack records to monitor quality and complications, which prevents the assessment of quality and the identification of areas for improvement.

Given the lack of evidence of the quality of ERCP in the Spanish population, the investigators will be conducting a multicenter, national prospective study that will include subjects who undergo ERCP.

Patient data and technical aspects of the procedure will be recorded and all included patients will be monitored to identify complications. The quality indicators obtained within the registry will be compared with those established by scientific societies and the relationship between complications and technical factors will be analyzed.

Eligibility criteria

Qualifiers

Over 18 years of age

Signed informed consent.

Disqualifiers

Under 18 years of age

Unavailability of informed consent

Impossibility of follow-up.

Trial design

Treatments tested in this trial

  • Endoscopic retrograde cholangiopancreatography (ERCP)

Treatment groups

3,000 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Germans Trias i Pujol Hospital

Lead sponsor

Spanish Society of Digestive Endoscopy

Collaborator